Table 2.
Characteristic | Baseline, n (%) | 6 months, n (%) | Percentage mean change | Generalized estimating equationa outcome effects over time | |||
OR (95% CI) | P value | ||||||
Total | 120 (100.0) | 88 (73.3) | —b | — | — | ||
HIV care continuum outcomes | |||||||
|
Received primary HIV care, last 6 months | ||||||
|
|
No | 21 (17.5) | 9 (10.2) | — | Reference | — |
|
|
Yes | 99 (82.5) | 79 (89.8) | 7.3 | 1.79 (0.82-3.93) | .14 |
|
Currently taking ARTc | ||||||
|
|
No | 27 (22.5) | 16 (18.2) | — | Reference | — |
|
|
Yes | 92 (76.7) | 72 (81.8) | 5.2 | 1.13 (0.70-1.83) | .61 |
|
Undetectable viral load | ||||||
|
|
No | 32 (26.7) | 13 (14.8) | — | Reference | — |
|
|
Yes | 65 (54.2) | 67 (76.1) | 22.0 | 2.16 (1.30-3.57) | .003 |
aThree generalized estimating equation models were used for the analyses: (1) odds of receiving primary HIV care at 6 months compared with baseline, (2) odds of taking ART at 6 months compared with baseline, and (3) odds of being virally suppressed at 6 months compared with baseline.
bNot applicable.
cART: antiretroviral therapy.